regimen while continuing to test three doses in the same age group. federal regulators hope it will be granted by the end of this month. let's start with this question. i wrote this down to make sure i got it right here. when pfizer released their findings in december, they found in children 6 months to 2 years, just a tenth of the adult dose created immune responses to those 16 to 25. not as strong in kids 2 to 4. that's why they are testing a third dose. they don't have the results from that. they will apply for this eua any way. should they wait for those or do you support that application coming in as soon as today? >> victor, that is a bit confusing, isn't it? a lot of us are scratching our heads and waiting to see the data on what basis would pfizer like to go ahead by a two dose